epoetin alfa (Formulation 2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for epoetin alfa (Formulation 2), covering 2017-02-27 to 2017-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Study of Two Formulations of Erythropoietin [Phase 3]